Latest Manufacturing News

Eureka Group Holdings has acquired a mixed-use residential park in Gladstone, marking its strategic entry into the all-age rental market with promising yield and expansion potential.

Resouro Strategic Metals reports outstanding assay results from its Tiros Central Project in Brazil, revealing high-grade titanium dioxide and rare earth elements that underscore the project's global significance.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

The Calmer Co. International Limited has secured a FJD2.64 million loan from Fiji Development Bank to acquire its Navua manufacturing site, marking a strategic step to enhance production and market presence in the global kava industry.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Little Green Pharma has finalized the acquisition of Health House, a key medicinal cannabis distributor, for a fraction of its previous valuation, marking a strategic move to deepen vertical integration.

VRX Silica Limited's Arrowsmith North silica sand project faces a formal appeal from the Conservation Council of WA, challenging the recent environmental approval recommendation. The company is preparing its response while continuing to advance parallel permitting processes.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director to steer the company through its next growth phase, while Rimas Kairaitis shifts focus to commercial strategy. The retirement of long-serving director Peter Nightingale marks the end of an era.